Bringing the fundamentals into focus…
Back to Charles River Laboratories International, Inc.
How Charles River Laboratories International, Inc. stacks up
CRL · against 552 other Healthcare companies listed in US-listed
Overall
37/ 100
Below the middle of the pack.
Ranked #338 of 553 · scores higher than 38% of peers
Bars: peers in each 10-point band of the overall score142 peers with an overall score of 30–39, including CRL · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CRL| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 338 | 397M USD | 37 | 8 | — | 5 | 0 / 2 | |
| 338 | 16.5B USD | 37 | 36 | 96 | 15 | 2 / 2 | |
| 338 | 100M USD | 37 | 33 | — | 19 | 1 / 2 | |
| 338 | 968M USD | 37 | 8 | — | 13 | 0 / 2 | |
| 338 | 16.9B USD | 37 | 43 | 29 | 62 | 2 / 2 | |
| 338 | 356.9B USD | 37 | 54 | 20 | 55 | 2 / 2 | |
| 338 | 2.2B USD | 37 | 62 | 23 | 47 | 2 / 2 | |
| 338 | 394M USD | 37 | 8 | 52 | 22 | 1 / 2 | |
| 347 | 7.7B USD | 36 | 8 | — | 9 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score